Skip to main content
PMC home page
Tissue Engineering and Regenerative Medicine logoLink to Tissue Engineering and Regenerative Medicine
. 2016 Oct 20;13(5):507–515. doi: 10.1007/s13770-016-9114-1

Bioreactor conditioning of valve scaffolds seeded internally with adult stem cells

Allison Kennamer 1, Leslie Sierad 1, Richard Pascal 1, Nicholas Rierson 1, Christopher Albers 1, Marius Harpa 2, Ovidiu Cotoi 2, Lucian Harceaga 2, Peter Olah 2, Preda Terezia 2, Agneta Simionescu 3, Dan Simionescu 1,2,✉
PMCID: PMC6170839  NIHMSID: NIHMS991355  PMID: 30337944

Abstract

The goal of this study was to test the hypothesis that stem cells, as a response to valve-specific extracellular matrix “niches” and mechanical stimuli, would differentiate into valvular interstitial cells (VICs). Porcine aortic root scaffolds were prepared by decellularization. After verifying that roots exhibited adequate hemodynamics in vitro, we seeded human adipose-derived stem cells (hADSCs) within the interstitium of the cusps and subjected the valves to in vitro pulsatile bioreactor testing in pulmonary pressures and flow conditions. As controls we incubated cell-seeded valves in a rotator device which allowed fluid to flow through the valves ensuring gas and nutrient exchange without subjecting the cusps to significant stress. After 24 days of conditioning, valves were analyzed for cell phenotype using immunohistochemistry for vimentin, alpha-smooth muscle cell actin (SMA) and prolyl-hydroxylase (PHA). Fresh native valves were used as immunohistochemistry controls. Analysis of bioreactor-conditioned valves showed that almost all seeded cells had died and large islands of cell debris were found within each cusp. Remnants of cells were positive for vimentin. Cell seeded controls, which were only rotated slowly to ensure gas and nutrient exchange, maintained about 50% of cells alive; these cells were positive for vimentin and negative for alpha-SMA and PHA, similar to native VICs. These results highlight for the first time the extreme vulnerability of hADSCs to valve-specific mechanical forces and also suggest that careful, progressive mechanical adaptation to valve-specific forces might encourage stem cell differentiation towards the VIC phenotype.

Key Words: Scaffolds, Heart valves, Stem cells, Bioreactor

References

  • 1.Wirrig EE, Yutzey KE. Conserved transcriptional regulatory mechanisms in aortic valve development and disease. Arterioscler Thromb Vasc Biol. 2014;34:737–741. doi: 10.1161/ATVBAHA.113.302071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mathieu P, Boulanger MC. Basic mechanisms of calcific aortic valve disease. Can J Cardiol. 2014;30:982–993. doi: 10.1016/j.cjca.2014.03.029. [DOI] [PubMed] [Google Scholar]
  • 3.Weiss RM, Miller JD, Heistad DD. Fibrocalcific aortic valve disease:opportunity to understand disease mechanisms using mouse models. Circ Res. 2013;113:209–222. doi: 10.1161/CIRCRESAHA.113.300153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Towler DA. Molecular and cellular aspects of calcific aortic valve disease. Circ Res. 2013;113:198–208. doi: 10.1161/CIRCRESAHA.113.300155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Akerström F, Barderas MG, Rodríguez-Padial L. Aortic stenosis:a general overview of clinical, pathophysiological and therapeutic aspects. Expert Rev Cardiovasc Ther. 2013;11:239–250. doi: 10.1586/erc.12.171. [DOI] [PubMed] [Google Scholar]
  • 6.Alexopoulos A, Kaoukis A, Papadaki H, Pyrgakis V. Pathophysiologic mechanisms of calcific aortic stenosis. Ther Adv Cardiovasc Dis. 2012;6:71–80. doi: 10.1177/1753944712439337. [DOI] [PubMed] [Google Scholar]
  • 7.Ladich E, Nakano M, Carter-Monroe N, Virmani R. Pathology of calcific aortic stenosis. Future Cardiol. 2011;7:629–642. doi: 10.2217/fca.11.53. [DOI] [PubMed] [Google Scholar]
  • 8.Chester AH, El-Hamamsy I, Butcher JT, Latif N, Bertazzo S, Yacoub MH. The living aortic valve:from molecules to function. Glob Cardiol Sci Pract. 2014;2014:52–77. doi: 10.5339/gcsp.2014.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Simionescu DT, Chen J, Jaeggli M, Wang B, Liao J. Form follows function:advances in trilayered structure replication for aortic heart valve tissue engineering. J Healthc Eng. 2012;3:179–202. doi: 10.1260/2040-2295.3.2.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Tedder ME, Simionescu A, Chen J, Liao J, Simionescu DT. Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering. Tissue Eng Part A. 2011;17:25–36. doi: 10.1089/ten.tea.2010.0138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Schoen FJ. Heart valve tissue engineering:quo vadis. Curr Opin Biotechnol. 2011;22:698–705. doi: 10.1016/j.copbio.2011.01.004. [DOI] [PubMed] [Google Scholar]
  • 12.Voges I, Bräsen JH, Entenmann A, Scheid M, Scheewe J, Fischer G, et al. Adverse results of a decellularized tissue-engineered pulmonary valve in humans assessed with magnetic resonance imaging. Eur J Cardiothorac Surg. 2013;44:e272–e279. doi: 10.1093/ejcts/ezt328. [DOI] [PubMed] [Google Scholar]
  • 13.Isenburg JC, Simionescu DT, Starcher BC, Vyavahare NR. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation. 2007;115:1729–1737. doi: 10.1161/CIRCULATIONAHA.106.672873. [DOI] [PubMed] [Google Scholar]
  • 14.Chow JP, Simionescu DT, Warner H, Wang B, Patnaik SS, Liao J, et al. Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol. Biomaterials. 2013;34:685–695. doi: 10.1016/j.biomaterials.2012.09.081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pennel T, Fercana G, Bezuidenhout D, Simionescu A, Chuang TH, Zilla P, et al. The performance of cross-linked acellular arterial scaffolds as vascular grafts;pre-clinical testing in direct and isolation loop circulatory models. Biomaterials. 2014;35:6311–6322. doi: 10.1016/j.biomaterials.2014.04.062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Colazzo F, Alrashed F, Saratchandra P, Carubelli I, Chester AH, Yacoub MH, et al. Shear stress and VEGF enhance endothelial differentiation of human adipose-derived stem cells. Growth Factors. 2014;32:139–149. doi: 10.3109/08977194.2014.945642. [DOI] [PubMed] [Google Scholar]
  • 17.Sierad LN, Simionescu A, Albers C, Chen J, Maivelett J, Tedder ME, et al. Design and testing of a pulsatile conditioning system for dynamic endothelialization of polyphenol-stabilized tissue engineered heart valves. Cardiovasc Eng Technol. 2010;1:138–153. doi: 10.1007/s13239-010-0014-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sierad LN, Shaw EL, Launius R, McBride S, Storholt C, Poole R, et al. Toward an endothelial-cell covered mechanical valve;surface re-engineering and bioreactor testing of mechanical heart valves. Chall Regen Med. 2014;1:22–34. [Google Scholar]
  • 19.Londono R, Badylak SF. Biologic scaffolds for regenerative medicine:mechanisms of in vivo remodeling. Ann Biomed Eng. 2015;43:577–592. doi: 10.1007/s10439-014-1103-8. [DOI] [PubMed] [Google Scholar]
  • 20.Keane TJ, Badylak SF. The host response to allogeneic and xenogeneic biological scaffold materials. J Tissue Eng Regen Med. 2015;9:504–511. doi: 10.1002/term.1874. [DOI] [PubMed] [Google Scholar]
  • 21.Badylak SF. Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine:factors that influence the host response. Ann Biomed Eng. 2014;42:1517–1527. doi: 10.1007/s10439-013-0963-7. [DOI] [PubMed] [Google Scholar]
  • 22.Tedder ME, Liao J, Weed B, Stabler C, Zhang H, Simionescu A, et al. Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng Part A. 2009;15:1257–1268. doi: 10.1089/ten.tea.2008.0263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chuang TH, Stabler C, Simionescu A, Simionescu DT. Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts. Tissue Eng Part A. 2009;15:2837–2851. doi: 10.1089/ten.tea.2008.0394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Colazzo F, Chester AH, Taylor PM, Yacoub MH. Induction of mesenchymal to endothelial transformation of adipose-derived stem cells. J Heart Valve Dis. 2010;19:736–744. [PubMed] [Google Scholar]
  • 25.Schoen FJ, Hobson CE. Anatomic analysis of removed prosthetic heart valves:causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol. 1985;16:549–559. doi: 10.1016/S0046-8177(85)80103-9. [DOI] [PubMed] [Google Scholar]
  • 26.Schoen FJ. Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium. J Heart Valve Dis. 1998;7:174–179. [PubMed] [Google Scholar]
  • 27.Rajamannan NM. The role of Lrp5/6 in cardiac valve disease:LDL-density-pressure theory. J Cell Biochem. 2011;112:2222–2229. doi: 10.1002/jcb.23182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rajamannan NM. Bicuspid aortic valve disease:the role of oxidative stress in Lrp5 bone formation. Cardiovasc Pathol. 2011;20:168–176. doi: 10.1016/j.carpath.2010.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Tissue Engineering and Regenerative Medicine are provided here courtesy of Springer

RESOURCES